298
Participants
Start Date
May 4, 2005
Primary Completion Date
February 23, 2016
Study Completion Date
February 23, 2016
Belimumab
Belimumab 10mg/kg IV over one hour every 28 days
GSK Investigational Site, Great Neck
GSK Investigational Site, Manhasset
GSK Investigational Site, Brooklyn
GSK Investigational Site, Albany
GSK Investigational Site, Rochester
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Willow Grove
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Wheaton
GSK Investigational Site, Baltimore
GSK Investigational Site, Baltimore
GSK Investigational Site, Cumberland
GSK Investigational Site, Winston-Salem
GSK Investigational Site, Charlotte
GSK Investigational Site, Atlanta
GSK Investigational Site, Aventura
GSK Investigational Site, Tampa
GSK Investigational Site, Birmingham
GSK Investigational Site, Louisville
GSK Investigational Site, Dayton
GSK Investigational Site, Munster
GSK Investigational Site, Milwaukee
GSK Investigational Site, Onalaska
GSK Investigational Site, Chicago
GSK Investigational Site, Chicago
GSK Investigational Site, St Louis
GSK Investigational Site, Kansas City
GSK Investigational Site, Lincoln
GSK Investigational Site, New Orleans
GSK Investigational Site, Baton Rouge
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Tulsa
GSK Investigational Site, Dallas
GSK Investigational Site, Houston
GSK Investigational Site, Sugar Land
GSK Investigational Site, Colorado Springs
GSK Investigational Site, Idaho Falls
GSK Investigational Site, Boise
GSK Investigational Site, Scottsdale
GSK Investigational Site, Tucson
GSK Investigational Site, Los Angeles
GSK Investigational Site, Los Angeles
GSK Investigational Site, Upland
GSK Investigational Site, La Jolla
GSK Investigational Site, San Jose
GSK Investigational Site, Sacramento
GSK Investigational Site, Seattle
GSK Investigational Site, Spokane
GSK Investigational Site, Orlando
GSK Investigational Site, Boston
GSK Investigational Site, Ann Arbor
GSK Investigational Site, Concord
GSK Investigational Site, Dover
GSK Investigational Site, Dallas
GSK Investigational Site, Arlington
GSK Investigational Site, Montreal
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Human Genome Sciences Inc., a GSK Company
INDUSTRY